Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
129.70
-0.91 (-0.70%)
Streaming Delayed Price
Updated: 11:34 AM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
42
43
Next >
Beat the Dow Jones With This Unstoppable Dividend Stock
January 03, 2023
This drugmaker is accustomed to outperforming the broader market.
Via
The Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,500 Today
December 28, 2022
Via
Benzinga
12 Recession-Proof Stocks
December 26, 2022
The stock market had a rough time in 2022. In this article, we are examining 12 dividend stocks whose recession-proof characteristics should enable them to keep growing their dividends in a bear market...
Via
Talk Markets
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
December 24, 2022
These companies are safe havens during tough times, with above-average dividends.
Via
The Motley Fool
3 Stocks on Santa's Nice List to Buy Before 2023
December 24, 2022
These stocks each offer something Santa would like.
Via
The Motley Fool
2 Beaten-Down Growth Stocks Set to Rebound in 2023
December 22, 2022
It'd be a mistake to write off these two healthcare leaders.
Via
The Motley Fool
2 Top Dividend Stocks to Buy Hand Over Fist Before 2023
December 16, 2022
These stocks will bring you income -- no matter what the market is doing.
Via
The Motley Fool
Here's How Much $100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
December 12, 2022
Via
Benzinga
Expert Ratings for Abbott Laboratories
December 12, 2022
Via
Benzinga
11 Analysts Have This to Say About Abbott Laboratories
December 12, 2022
Via
Benzinga
2 Exceptional Dividend Growth Stocks to Buy Now
December 20, 2022
These companies have histories of rapid payout increases and the means to continue them.
Via
The Motley Fool
1 Passive Income Stock to Buy Today, and 1 to Avoid for Now
December 18, 2022
Rising interest rates don't affect all passive income stocks equally.
Via
The Motley Fool
2022 Bargain Shopping: 2 Smart Stocks to Buy Before the New Year
December 18, 2022
These stocks look cheap -- especially considering their long-term potential.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 16, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait
December 16, 2022
These companies will work hard to grow your base of passive income.
Via
The Motley Fool
2 Supercharged Dividend Stocks to Buy in a Bear Market
December 09, 2022
Don't let these income stocks pass you by.
Via
The Motley Fool
2 Dividend Stocks That Could Double Your Return in 10 Years
December 16, 2022
Both companies should hurdle their patent cliff concerns.
Via
The Motley Fool
Why Abbott Laboratories Topped the Market on Tuesday
December 13, 2022
Bullish momentum behind the big pharmaceutical company was aided by a glowing new analyst note.
Via
The Motley Fool
A Career Politician Who Regularly Trades The SPY, Picked Up There 3 High Yielding ETFs Instead
December 13, 2022
Representative Robert Wittman (R-VA) is the vice-ranking member of the House Armed Services Committee and also serves on the Committee on Natural Resources.
Via
Benzinga
Reliable Passive Income: an Analysis on Dividend Kings
December 13, 2022
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat.
Via
The Motley Fool
Two Blue Chip Health Companies The Institutions Are Buying
December 12, 2022
Johnson & Johnson and Abbott Laboratories are two Dividend Kings the analysts are buying, one stock is ready to rebound and the other to lead the market.
Via
MarketBeat
2 Ultra-Reliable Dividend Stocks You Can Buy Now and Hold Forever
December 10, 2022
Here are two stocks that investors can count on to deliver increasing dividend payments for many years to come.
Via
The Motley Fool
Have $1,000? 2 Top Dividend Stocks to Buy Right Now
December 09, 2022
Dividend stocks can help investors grow their portfolios in all types of markets.
Via
The Motley Fool
2 Dividend Aristocrats to Buy for 2023
December 07, 2022
You can count on these dividend stocks to continue raising their payouts for years to come.
Via
The Motley Fool
Got $500? Where to Invest It Before 2023
December 06, 2022
These top stocks look like a deal right now.
Via
The Motley Fool
Is AbbVie Stock a Buy Now?
December 06, 2022
The pharmaceutical company prepared well as Humira approaches its patent cliff next year.
Via
The Motley Fool
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
December 02, 2022
Via
Benzinga
3 Top Dividend Kings to Buy for the Long Haul
November 30, 2022
Dividend stocks are an easy option to boost income.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
42
43
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.